MedTrace Logo

FCI Effectiveness in NAFLD Stratification

NCT05827432 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-04-01

No results posted yet for this study

Summary

The goal of this pilot study is exploring whether field-cycling imaging may be able to detect characteristics of liver disease in patients with different degree of non-alcoholic fatty liver disease (NAFLD) that could be important in reflecting disease progression.

Conditions

  • Non-Alcoholic Fatty Liver Disease

Interventions

DEVICE

Field-cycling imaging (FCI)

FCI scan

Sponsors & Collaborators

  • University of Aberdeen

    collaborator OTHER

  • NHS Grampian

    lead OTHER_GOV

Principal Investigators

  • Ashis Mukhopadhya, Dr · NHS Grampian

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-31
Primary Completion
2026-03-31
Completion
2026-03-26

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05827432 on ClinicalTrials.gov